MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value
Clover Health Investments (CLOV) had its price target lowered by Canaccord Genuity Group Inc. from $3.70 to $3.20. They now have a "buy" rating on the stock.
Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
Clover Health Investments Touts AI Medicare Advantage Model, Targets GAAP Profitability in 2026 at Leerink Conference [Yahoo! Finance]
UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives [Yahoo! Finance]